Heparin with or without alteplase in patients with submassive pulmonary embolism: effects on right ventricular dysfunction

Trial Profile

Heparin with or without alteplase in patients with submassive pulmonary embolism: effects on right ventricular dysfunction

Completed
Phase of Trial: Phase II

Latest Information Update: 31 Jan 2011

At a glance

  • Drugs Alteplase (Primary) ; Heparin
  • Indications Pulmonary embolism; Right ventricular hypertrophy
  • Focus Therapeutic Use
  • Most Recent Events

    • 31 Jan 2011 Primary endpoint 'Cardiovascular-function-parameters' has been met
    • 30 Jan 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top